FDA
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XL Fleet Corp., Bellus Health, Neptune Wellness, and Sequential Brands and Encourages Investors to Cont
-
-
-
-
-
-
-
Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020
-
-
-
-
-
-
-
Neptune Successfully Completes Submission to U.S. FDA for Registration of its Conover, NC Facility for Production of Hand Sanitizers
-
-
-
-
-
-
-
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
-
-
-
-
-
-
-
Acasti Pharma (ACST) Announces Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for Treatment of Severe Hypertriglyceridemia
-
-
-
-
-
-
-
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
-
-
-
-
-
-
-
Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

